MENU
+Compare
VTVT
Stock ticker: NASDAQ
AS OF
Jul 16, 04:56 PM (EDT)
Price
$16.99
Change
+$0.11 (+0.65%)
Capitalization
44.18M

VTVT vTv Therapeutics Forecast, Technical & Fundamental Analysis

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients... Show more

Industry: #Biotechnology
VTVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VTVT with price predictions
Jul 15, 2025

VTVT in +9.31% Uptrend, growing for three consecutive days on July 10, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VTVT advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 08, 2025. You may want to consider a long position or call options on VTVT as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VTVT just turned positive on June 24, 2025. Looking at past instances where VTVT's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 44 cases where VTVT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTVT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VTVT broke above its upper Bollinger Band on July 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VTVT entered a downward trend on July 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.577) is normal, around the industry mean (17.548). P/E Ratio (0.000) is within average values for comparable stocks, (58.754). VTVT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.452). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. VTVT's P/S Ratio (5000.000) is very high in comparison to the industry average of (269.838).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VTVT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VTVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VTVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VTVT is expected to report earnings to fall 90.91% to -7 cents per share on February 28

vTv Therapeutics VTVT Stock Earnings Reports
Q4'23
Est.
$-0.07
Q1'25
Beat
by $0.33
Q3'23
Est.
$-0.08
Q2'23
Missed
by $2.73
Q1'23
Beat
by $0.05
The last earnings report on May 15 showed earnings per share of -76 cents, beating the estimate of -110 cents. With 794.00 shares outstanding, the current market capitalization sits at 44.18M.
A.I. Advisor
published General Information

General Information

a clinical-stage pharmaceutical holding company, which focuses on the discovery and development of human therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3980 Premier Drive
Phone
+1 336 841-0300
Employees
16
Web
https://www.vtvtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RITR4.770.17
+3.70%
Reitar Logtech Holdings Ltd.
ETWO3.27N/A
N/A
E2open Parent Holdings
TKR76.33-0.97
-1.25%
Timken Company (The)
MURA2.49-0.05
-1.97%
Mural Oncology plc
DHR192.86-4.89
-2.47%
Danaher Corp

VTVT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTVT has been loosely correlated with VANI. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VTVT jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTVT
1D Price
Change %
VTVT100%
+1.02%
VANI - VTVT
59%
Loosely correlated
+2.01%
CMND - VTVT
34%
Loosely correlated
-1.70%
VTYX - VTVT
33%
Poorly correlated
+7.83%
ZNTL - VTVT
32%
Poorly correlated
-1.47%
IPSC - VTVT
29%
Poorly correlated
-3.58%
More